MacroGenics
MGNX
144 hedge funds and large institutions have $528M invested in MacroGenics in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 58 increasing their positions, 38 reducing their positions, and 32 closing their positions.
1,211% more call options, than puts
Call options by funds: $498K | Put options by funds: $38K
53% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 38
4.96% more ownership
Funds ownership: 93.38% → 98.34% (+5%)
8% less funds holding
Funds holding: 156 → 144 (-12)
38% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 32
43% less capital invested
Capital invested by funds: $918M → $528M (-$390M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$25.4M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$11.9M |
| 3 |
State Street
Boston,
Massachusetts
|
+$6.98M |
| 4 |
Renaissance Technologies
New York
|
+$6.47M |
| 5 |
Millennium Management
New York
|
+$5.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$20.2M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$16.1M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$13.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.16M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$3.2M |
MGNX Hedge Fund Activity: Q1 2022 in Review
144 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2022, worth a combined $528M — down 43% from $918M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of MGNX and 20 opened new positions — a net loss of 12 holders — while 38 trimmed existing stakes and 58 added.
The largest buyer was Armistice Capital, adding an estimated $25.4M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $20.2M sold.
- 144 institutional investors held MacroGenics (MGNX) as of Q1 2022, down from 156 in Q4 2021.
- Funds reported $528M of MacroGenics stock for Q1 2022, down 43% quarter-over-quarter.
- 20 funds opened new MacroGenics positions in Q1 2022 and 32 closed out, a net change of -12 holders.
- The largest MacroGenics buyer in Q1 2022 was Armistice Capital, an estimated $25.4M added.
- The largest MacroGenics seller in Q1 2022 was Point72 Asset Management, an estimated $20.2M sold.
Based on aggregated 13F filings for Q1 2022.